Cargando…
Topical Administration of Mometasone Is Not Helpful in Post-COVID-19 Olfactory Dysfunction
Persistent olfactory dysfunction is a major concern post-COVID-19, affecting up to 5% of all patients. Different therapeutic options, including mometasone nasal spray, have been recommended, only some of which have been validated for post-COVID-19 olfactory dysfunction. In this study we psychophysic...
Autores principales: | Hintschich, Constantin A., Dietz, Melanie, Haehner, Antje, Hummel, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605508/ https://www.ncbi.nlm.nih.gov/pubmed/36294918 http://dx.doi.org/10.3390/life12101483 |
Ejemplares similares
-
Odours count: human olfactory ecology appears to be helpful in the improvement of the sense of smell
por: Oleszkiewicz, Anna, et al.
Publicado: (2021) -
Olfactory Loss in Parkinson's Disease
por: Haehner, Antje, et al.
Publicado: (2011) -
Persisting olfactory dysfunction in post-COVID-19 is associated with gustatory impairment: Results from chemosensitive testing eight months after the acute infection
por: Hintschich, Constantin A., et al.
Publicado: (2022) -
COVID-19–induced olfactory loss
por: Stuck, Boris A., et al.
Publicado: (2023) -
Symptoms of depression change with olfactory function
por: Sabiniewicz, Agnieszka, et al.
Publicado: (2022)